Johnson & Johnson

NYSE: JNJ
$163.49
-$0.67 (-0.4%)
Real Time Data Delayed 15 Min.

JNJ Articles

Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of December 30, 2011. These public stock holdings have been broken...
Johnson & Johnson (NYSE: JNJ) managed to marginally beat earnings expectations this Tuesday morning.  This is the first of the consumer products and medical products companies to report, so this...
This coming week is going to be yet another action packed week of big corporate earnings which will move markets or will move their sectors.  24/7 Wall St. has identified each of the DJIA components...
The coming week is going to be yet another action packed week of big corporate earnings which will move markets or will move their sectors.  24/7 Wall St. has identified the DJIA components...
Customers, employees, shareholders and taxpayers hate large corporations for many reasons. 24/7 Wall St. reviewed a lengthy list of corporations for which there is substantial research data to choose...
Each January, 24/7 Wall St. forecasts the publicly traded U.S. companies that will have the highest profits in the year ahead. This year, Apple (NASDAQ: AAPL) is likely to pass Exxon Mobil (NYSE:...
The lineup of the Dogs of the Dow, simply the ten highest dividend yield stocks of the thirty Dow Jones Industrial Average components, appears to be undergoing a bit of change for 2012.  There is a...
Sony (NYSE: SNE) will sell its LCD business to Samsung for $940 million. (Reuters) The yuan hits a high against the dollar and may gain 4% this year. (Reuters) Amazon.com’s (NASDAQ: AMZN) program...
Throughout December we have been giving updates on dividends that will rise in the coming days and weeks from the 30 Dow Jones Industrial Average stocks. Many have already come true and others are...
Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company (NYSE: DIS) joined in on the dividend hike brigade with another dividend...
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like the movie business, a drug company tries to develop that...
The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain for companies to continue returning capital to shareholders while also looking for...